Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

Jefferies analyst Lloyd Byrne adjusted the price target for Bloom Energy Corp . (NYSE:BE) shares, reducing it to $21.00 from the previous $22.00 while maintaining a Hold rating on the stock. Currently ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The Pill prevents pregnancy -- and maybe ovarian cancer, too, a new study ...

Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, ...

Amgen (NASDAQ:AMGN – Free Report) had its price target decreased by Citigroup from $310.00 to $295.00 in a research report released on Tuesday morning,Benzinga reports. Citigroup currently has a ...

Amgen (NASDAQ:AMGN – Get Free Report) is expected to be issuing its quarterly earnings data after the market closes on ...

Following a strong Q4 and 2024, T-Mobile US highlighted how its Starlink Satellite connectivity aided the victims of ...

This study presents a useful finding that targeting amino acid metabolism can overcome Trastuzumab resistance in HER2+ breast cancer. The evidence supporting the claims of the authors is solid and the ...

A case report described an infant with concurrent HDFN and SMA who was succesfully treated with an onasemnogene abeparvovec infusion.

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...